- CUSIP
- 88634T469
- Issuer
- YieldMax
- Inception Date
- Oct 23, 2023
- Category
- Derivative Income, Dividend
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Alternatives
- Assets Under Management
- $89M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MRNY Performance Chart
YieldMax MRNA Option Income Strategy ETF (MRNY) is up 47.1% since the beginning of the year. MRNY is currently trading at $15 per share.
Loading charts...
Returns By Period
YieldMax MRNA Option Income Strategy ETF (MRNY) has returned 47.14% so far this year and 43.13% over the past 12 months.
YieldMax MRNA Option Income Strategy ETF
- 1D
- -5.48%
- 1M
- -8.37%
- YTD
- 47.14%
- 6M
- 49.33%
- 1Y
- 43.13%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -2.64%
- 1M
- -0.21%
- YTD
- 7.86%
- 6M
- 7.47%
- 1Y
- 23.05%
- 3Y*
- 19.90%
- 5Y*
- 11.79%
- 10Y*
- 13.33%
MRNY Monthly Returns History
Based on dividend-adjusted daily data since Oct 24, 2023, MRNY's average daily return is -0.07%, while the average monthly return is -1.50%.
Historically, 39% of months were positive and 61% were negative. The best month was Jan 2026 with a return of +38.8%, while the worst month was Aug 2024 at -30.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.
On a daily basis, MRNY closed higher 49% of trading days. The best single day was Jan 21, 2026 with a return of +13.6%, while the worst single day was Aug 1, 2024 at -20.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 38.78% | 14.67% | -1.27% | -9.58% | 3.94% | -0.36% | 47.14% | ||||||
| 2025 | -10.46% | -19.84% | -7.70% | 0.09% | -3.94% | 6.37% | 1.80% | -17.44% | 6.24% | 5.39% | -3.62% | 4.59% | -35.72% |
| 2024 | -0.39% | -4.45% | 13.90% | 3.28% | -4.89% | -14.82% | 4.00% | -30.05% | -10.50% | -14.27% | -18.55% | -1.36% | -59.32% |
| 2023 | -3.72% | -1.39% | 25.99% | 19.61% |
Benchmark Metrics
YieldMax MRNA Option Income Strategy ETF has an annualized alpha of -34.48%, beta of 1.13, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 25, 2023.
- This ETF participated in 115.79% of S&P 500 Index downside but only -40.39% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.12 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -34.48%
- Beta
- 1.13
- R²
- 0.12
- Upside Capture
- -40.39%
- Downside Capture
- 115.79%
Expense Ratio
MRNY has a high expense ratio of 0.99%, indicating above-average management fees.
Return for Risk
Risk / Return Rank
MRNY ranks 31 for risk / return — below 31% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for YieldMax MRNA Option Income Strategy ETF (MRNY) and compare them to S&P 500 Index.
| MRNY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.02 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.36 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.55 | 2.69 | -1.14 |
| Martin ratioReturn relative to average drawdown | 3.01 | 12.34 | -9.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
YieldMax MRNA Option Income Strategy ETF provided a 105.86% dividend yield over the last twelve months, with an annual payout of $16.08 per share.
| Period | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Dividend | $16.08 | $21.46 | $93.89 | $4.13 |
Dividend yield | 105.86% | 145.98% | 178.49% | 1.75% |
Monthly Dividends
The table displays the monthly dividend distributions for YieldMax MRNA Option Income Strategy ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $1.44 | $1.31 | $1.43 | $1.27 | $0.81 | $0.21 | $6.47 | ||||||
| 2025 | $5.24 | $2.31 | $1.83 | $1.26 | $1.22 | $1.90 | $2.00 | $0.95 | $0.76 | $1.92 | $0.96 | $1.12 | $21.46 |
| 2024 | $26.54 | $5.94 | $11.31 | $7.83 | $9.47 | $8.45 | $4.90 | $4.66 | $4.79 | $3.76 | $4.01 | $2.22 | $93.89 |
| 2023 | $4.13 | $4.13 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the YieldMax MRNA Option Income Strategy ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the YieldMax MRNA Option Income Strategy ETF was 82.15%, occurring on Nov 20, 2025. The portfolio has not yet recovered.
The current YieldMax MRNA Option Income Strategy ETF drawdown is 69.02%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -82.15%Nov 2025 | 1y 5mo | — | 2y 11dMay 2024 - now |
2024 bear market2024 | -20.83%Feb 2024 | 1mo 5d | 1mo 11d | 2mo 16dJan 2024 - Mar 2024 |
2023 correction2023 | -11.09%Nov 2023 | 15d | 1mo 2d | 1mo 17dOct 2023 - Dec 2023 |
2024 pullback2024 | -6.19%Apr 2024 | 6d | 6d | 12dMar 2024 - Apr 2024 |
2024 pullback2024 | -5.64%May 2024 | 7d | 5d | 12dMay 2024 - May 2024 |
Drawdown Indicators
| MRNY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.15% | -56.78% | -25.37% |
Max Drawdown (1Y)Largest decline over 1 year | -31.53% | -9.10% | -22.43% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -69.02% | -2.97% | -66.05% |
Average DrawdownAverage peak-to-trough decline | -52.66% | -10.72% | -41.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.17% | 1.97% | +14.20% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with MRNY
Add YieldMax MRNA Option Income Strategy ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MRNY